Prevalence of clinical and ultrasound enthesitis in patients with hidradenitis suppurativa

Prevalence of clinical and ultrasound enthesitis in patients with hidradenitis suppurativa - EntHS-study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46310

Enrollment

100

Registered

2018-10-19

Start date

2018-10-22

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne inversa hidradenitis suppurativa

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older Mentally competent Diagnosed with HS according to the European guidelines of dermatology

Exclusion criteria

Exclusion criteria: No written informed consent Poor knowledge of the Dutch language

Design outcomes

Primary

Measure	Time frame
To determine the prevalence of enthesitis in HS patients using physical examination, according to the MASE, and ultrasound, according to the MASEI, as golden standard	—

Secondary

Measure	Time frame
- To determine the prevalence of clinical arthritis of patients with HS. - To determine the prevalence of dactylitis in patients with HS. - To determine the prevalence of inflammatory backpain in patients with HS. - To determine the prevalence of extra-articular SpA features, like psoriasis, IBD and uveitis, in patients with HS. - To determine the quality of life of patients with HS and SpA features.	—

Measure

Time frame

- To determine the prevalence of clinical arthritis of patients with HS. - To determine the prevalence of dactylitis in patients with HS. - To determine the prevalence of inflammatory backpain in patients with HS. - To determine the prevalence of extra-articular SpA features, like psoriasis, IBD and uveitis, in patients with HS. - To determine the quality of life of patients with HS and SpA features.

—

Countries

Netherlands

Outcome results